Special Investigation (Long-term Investigation) in Patients With Crohn's Disease

Trial Profile

Special Investigation (Long-term Investigation) in Patients With Crohn's Disease

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Apr 2017

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Crohn's disease
  • Focus Adverse reactions
  • Sponsors Abbott Laboratories; AbbVie
  • Most Recent Events

    • 03 Aug 2016 Planned End Date changed from 1 May 2016 to 1 Oct 2018.
    • 03 Aug 2016 Planned primary completion date changed from 1 May 2016 to 1 Oct 2018.
    • 07 Aug 2015 Planned End Date changed from 1 Mar 2017 to 1 May 2016, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top